Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Touch Bionics is a provider of world-leading prosthetic technologies and supporting services designed to ensure the best possible outcomes for people with upper limb deficiencies. The company is best known for developing the i-Limb, the world's first multi-articulating prosthetic hand, which allows users to perform complex tasks with greater ease and natural movement. Their product portfolio includes a range of prosthetic hands, partial hand solutions, and highly realistic passive functional prostheses. Following its acquisition by Össur in 2016, Touch Bionics continues to innovate in the field of bionic limbs, integrating advanced software and gesture control to enhance user autonomy. The company's solutions are used globally by clinicians and patients to restore function and improve quality of life.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Touch Bionics.